Eris Lifesciences Annual General Meeting
Eris Lifesciences Limited conducted its 20th Annual General Meeting on September 25, 2026. Shareholders transacted business including the adoption of audited financial statements and director re-appointments.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
5 announcements with these filters
Eris Lifesciences Limited conducted its 20th Annual General Meeting on September 25, 2026. Shareholders transacted business including the adoption of audited financial statements and director re-appointments.
Eris Lifesciences will hold its Twentieth Annual General Meeting on September 25, 2026, through video conferencing to transact ordinary and special business.
Eris Lifesciences announced postal ballot results confirming Mr. Vineet Varma’s appointment as an Independent Director. Shareholders approved the resolution with a 99.92% majority.
Eris Lifesciences Limited has issued a postal ballot notice seeking shareholder approval via special resolution for the appointment of Mr. Vineet Varma as an Independent Director. The proposed tenure is for five years, effective from March 14, 2026, to March 13, 2031.
Eris Lifesciences Limited has issued a postal ballot notice to seek shareholder approval for the appointment of Mr. Vineet Varma as an Independent Director for a five-year term. The remote e-voting period runs from April 24, 2026, to May 23, 2026. This appointment aims to strengthen the board with his extensive international banking experience.